AngioLab Inc 251280

Morningstar Rating
₩2,100.00 +15.00 (0.72%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

251280 is trading at a LOCK|ZKl>b& premium.
Price
₩2,085.00
Fair Value
LOCK|Z@.@bf%!F>>
Uncertainty
LOCK|cz ZlcJ
1-Star Price
LOCK|y&.Z@@ng
5-Star Price
LOCK|&J.D>b@twM
Economic Moat
LOCK|>$@!
Capital Allocation
—

Trading Information

Previous Close Price
₩2,085.00
Day Range
₩2,100.00–2,100.00
52-Week Range
₩1,523.00–4,200.00
Bid/Ask
₩2,085.00 / ₩2,095.00
Shares Outstanding
3.11M
Market Cap
₩6.54B
Volume/Avg
21 / 1,589

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
2.89
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

AngioLab Inc is a biotechnology company. It is developing pharmaceuticals and health functional foods based on the inhibition of angiogenesis. The group is developing natural products and antibody-based pharmaceuticals.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
16

Valuation

Metric
251280
Price/Earnings (Normalized)
—
Price/Book Value
6.79
Price/Sales
2.89
Price/Cash Flow
—
Price/Earnings
251280

Financial Strength

Metric
251280
Quick Ratio
1.46
Current Ratio
2.18
Interest Coverage
−377.82
Quick Ratio
251280

Profitability

Metric
251280
Return on Assets (Normalized)
−23.43%
Return on Equity (Normalized)
−91.62%
Return on Invested Capital (Normalized)
−42.79%
Return on Assets
251280

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|@hq!!MLOCK|^Y$<K$135B
Regeneron Pharmaceuticals Inc
REGN
LOCK|XzS%>hLOCK|%dP%?$99B
Moderna Inc
MRNA
LOCK|bcfbZ%LOCK|h!$84B
argenx SE ADR
ARGX
LOCK|&#L^HDLOCK|>p$59B
BeOne Medicines Ltd ADR
ONC
LOCK|T%vP%JKLOCK|qg$48B
Royalty Pharma PLC Class A
RPRX
LOCK|fhyf<XhXLOCK|%QhmR$31B
Incyte Corp
INCY
LOCK|nzygt!^LOCK|<Vg$24B
BioNTech SE ADR
BNTX
LOCK|^SC?Z^LOCK|K&P$21B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|$xYD%nLOCK|k%Tw$21B
Jazz Pharmaceuticals PLC
JAZZ
LOCK|Z&zWV%YLOCK|$h$15B

Sponsor Center